Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rotem Fishel Ben Kenan"'
Publikováno v:
Annals of hematology.
Autor:
Steven G. DuBois, Rotem Fishel Ben Kenan, Steve Braunstein, Katherine K. Matthay, Daphne A. Haas-Kogan, Alexei L. Polishchuk, Randall A. Hawkins
Publikováno v:
Pediatric Blood & Cancer. 69
Objectives Patients with metaiodobenzylguanidine (MIBG)-avid relapsed or refractory neuroblastoma after initial therapy may exhibit transient responses to salvage treatment with iodine-131 metaiodobenzylguanidine (131 I-MIBG). It is unclear whether d
Autor:
Rotem, Fishel Ben Kenan, Alexei L, Polishchuk, Randall A, Hawkins, Steve E, Braunstein, Katherine K, Matthay, Steven G, DuBois, Daphne A, Haas-Kogan
Publikováno v:
Pediatric bloodcancerREFERENCES. 69(2)
Patients with metaiodobenzylguanidine (MIBG)-avid relapsed or refractory neuroblastoma after initial therapy may exhibit transient responses to salvage treatment with iodine-131 metaiodobenzylguanidine (Patients with relapsed or refractory metastatic
Autor:
Liang Chen, Wei Xu, Bianxiao Cui, Yasuko Osakada, Xiaobei Zhao, Rotem Fishel Ben Kenan, Rachel S. Sinit, Jia-Yun Chen, Kai Zhang, Chengbiao Wu
Publikováno v:
The Journal of Neuroscience. 33:7451-7462
Retrograde trophic signaling of nerve growth factor (NGF) supports neuronal survival and differentiation. Dysregulated trophic signaling could lead to various neurological disorders. Charcot-Marie-Tooth type 2B (CMT2B) is one of the most common inher